Pagaya Reports Third Quarter 2022 Results
3Q’22 Network Volume grows 26% year-over-year to
Total Revenue grows 49% year-over-year to reach record
Adjusted EBITDA of
“We delivered another quarter of strong network volume and total revenue growth year-over-year, resulting in the highest quarterly revenue in our 6-year history. These results reflect the power of the network infrastructure we have created, the “rails” that connect our partners, investors, and consumers across the country,” said
Third Quarter 2022 Financial Highlights
All comparisons are made versus the same period in 2021 unless otherwise stated
- Network Volume increased 26% to
$1.9 billion , reflecting strong growth from existing partnerships and newer products - Total revenue and other income increased 49% to
$204.0 million , mainly due to increased fee revenue from Network Volume growth - Net loss attributable to
Pagaya shareholders of$74.8 million , impacted by share-based compensation of$60.3 million . Adjusted net loss of$14.4 million , which excludes share-based compensation expense, a change in fair value of warrant liability and non-recurring expenses - Adjusted EBITDA of negative
$5.2 million , reflecting lower margins in newer programs, financial markets volatility and ongoing investment in the business
Recent Business Highlights
- Network expansion: Monthly application flow from existing partners grew by approximately 20% from January to
September 2022 . Top 3 Auto partner onboarded in May enabling further expansion in Auto product, with dealership representation in over 70% of allU.S. franchise dealerships. Top-tier PoS partner onboarded onto the Company’s platform - Consistently raising capital: Raised over
$2 billion of investor capital into financing vehicles in the third quarter, in both public and private capital markets. Triple-A rating achieved from Moody’s and DBRS on Company’s most recent single-family-rental ABS transaction - Strengthening Pagaya’s network infrastructure: Continued strong application flow from existing and new partners, with 77 million applications evaluated from the beginning of 2019 through the third quarter of 2022. 41 million applications evaluated in the first nine months of 2022, representing 120% growth compared to the same period last year
Full-Year 2022 Outlook
The Company is maintaining its prior outlook for full-year 2022, with Network Volume and Adjusted EBITDA expected to be at the low end of their respective ranges.
|
FY22 |
|
Network Volume |
Expected to range between |
|
Total Revenue |
Expected to range between |
|
Adjusted EBITDA |
Expected to range between negative |
Webcast
The Company will hold a webcast and conference call today,
The conference call can also be accessed by dialing 1-888-396-8064 or 1-416-764-8649. The telephone replay can be accessed by dialing 1-844-512-2921 or 1-412-317-6671 and providing the conference ID# 00585771. The telephone replay will be available starting shortly after the call until
About
Cautionary Note About Forward-Looking Statements
This document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve risks and uncertainties. These forward-looking statements generally are identified by the words “anticipate”, “believe”, “continue”, “can,” “could”, “estimate”, “expect”, “intend”, “may”, “opportunity”, “future”, “strategy”, “might”, “outlook”, “plan”, “possible”, “potential”, “predict”, “project”, “should”, “strive”, “will,” “would”, “will be”, “will continue”, “will likely result”, and similar expressions. All statements other than statements of historical fact are forward-looking statements, including statements regarding: the Company's strategy and future operations, including the Company's partnerships with certain key providers; the development, innovation, introduction and performance of, and demand for, the Company's products and services; the Company’s ability to continue to invest in the long-term growth and scalability of its business; the Company's future growth, investments, brand awareness, financial position, gross market value, revenue, transaction costs, operating income, provision for credit losses, and cash flows; and general economic trends and trends in the Company's industry and markets; and the Company’s financial outlook for the full year of 2022. These forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Risks, uncertainties and assumptions include factors relating to: the Company's ability to attract new partners and to retain and grow its relationships with existing partners to support the underlying investment needs for its securitizations and funds products; the need to maintain a consistently high level of trust in its brand; the concentration of a large percentage of its investment revenue with a small number of partners and platforms; its ability to sustain its revenue growth rate or the growth rate of its related key operating metrics; its ability to improve, operate and implement its technology, its existing funding arrangements for the Company and its affiliates that may not be renewed or replaced or its existing funding sources that may be unwilling or unable to provide funding to it on terms acceptable to it, or at all; the performance of loans facilitated through its model; changes in market interest rates; its securitizations, warehouse credit facility agreements; the impact on its business of general economic conditions, including, but not limited to rising interest rates, inflation, supply chain disruptions, exchange rate fluctuations and labor shortages; the effect of and uncertainties related to the COVID-19 pandemic (including any government responses thereto); the financial performance of its partners, and fluctuations in the
Financial Information; Non-GAAP Financial Measures
Some of the financial information and data contained in this press release and Form 6-K, such as Adjusted EBITDA, have not been prepared in accordance with
Non-GAAP financial measures include the following item:
Adjusted Net Income (Loss) is defined as net income (loss) attributable to Pagaya Technologies Ltd.’s shareholders excluding share-based compensation expense, change in fair value of warrant liability, and non-recurring expenses associated with the business combination with
Adjusted EBITDA is defined as net income (loss) attributable to Pagaya Technologies Ltd.’s shareholders excluding share-based compensation expense, change in fair value of warrant liability, non-recurring expenses associated with the Merger, interest expense, depreciation expense, and provision for income taxes.
These items are excluded from our Adjusted Net Income (Loss) and Adjusted EBITDA measures because they are noncash in nature, or because the amount and timing of these items is unpredictable, is not driven by core results of operations and renders comparisons with prior periods and competitors less meaningful.
We believe Adjusted Net Income (Loss) and Adjusted EBITDA provide useful information to investors and others in understanding and evaluating our results of operations, as well as providing a useful measure for period-to-period comparisons of our business performance. Moreover, we have included Adjusted Net Income (Loss) and Adjusted EBITDA because these are key measurements used by our management internally to make operating decisions, including those related to operating expenses, evaluate performance, and perform strategic planning and annual budgeting. However, this non-GAAP financial information is presented for supplemental informational purposes only, should not be considered a substitute for or superior to financial information presented in accordance with GAAP and may be different from similarly titled non-GAAP financial measures used by other companies. The tables below provide reconciliations of Adjusted EBITDA to Net Loss Attributable to
In addition, outlook for the fiscal year, where adjusted, is provided on a non-GAAP basis, which
|
|||||||||||||||
UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS |
|||||||||||||||
FOR THREE AND NINE MONTHS ENDED |
|||||||||||||||
(In thousands, except share and per share data) |
|||||||||||||||
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Revenue |
|
|
|
|
|
|
|
||||||||
Revenue from fees |
$ |
185,614 |
|
|
$ |
128,149 |
|
|
$ |
507,241 |
|
|
$ |
301,604 |
|
Other Income |
|
|
|
|
|
|
|
||||||||
Interest income |
|
13,666 |
|
|
|
8,455 |
|
|
|
43,127 |
|
|
|
18,256 |
|
Investment income (loss) |
|
4,675 |
|
|
|
(14 |
) |
|
|
5,670 |
|
|
|
(2 |
) |
Total Revenue and Other Income |
|
203,955 |
|
|
|
136,590 |
|
|
|
556,038 |
|
|
|
319,858 |
|
Costs and Operating Expenses |
|
|
|
|
|
|
|
||||||||
Production costs |
|
129,115 |
|
|
|
81,731 |
|
|
|
326,375 |
|
|
|
181,505 |
|
Research and development(1) |
|
38,643 |
|
|
|
11,932 |
|
|
|
127,379 |
|
|
|
51,344 |
|
Sales and marketing(1) |
|
26,579 |
|
|
|
9,161 |
|
|
|
90,229 |
|
|
|
37,564 |
|
General and administrative(1) |
|
73,790 |
|
|
|
18,961 |
|
|
|
236,863 |
|
|
|
53,068 |
|
Total Costs and Operating Expenses |
|
268,127 |
|
|
|
121,785 |
|
|
|
780,846 |
|
|
|
323,481 |
|
Operating Income (Loss) |
|
(64,172 |
) |
|
|
14,805 |
|
|
|
(224,808 |
) |
|
|
(3,623 |
) |
Other income (loss), net(2) |
|
3,233 |
|
|
|
(32,768 |
) |
|
|
9,846 |
|
|
|
(51,539 |
) |
Income (Loss) Before Income Taxes |
|
(60,939 |
) |
|
|
(17,963 |
) |
|
|
(214,962 |
) |
|
|
(55,162 |
) |
Income tax expense(2) |
|
6,065 |
|
|
|
3,624 |
|
|
|
25,604 |
|
|
|
11,417 |
|
Net Loss |
|
(67,004 |
) |
|
|
(21,587 |
) |
|
|
(240,566 |
) |
|
|
(66,579 |
) |
Less: Net income attributable to noncontrolling interests |
|
7,785 |
|
|
|
6,570 |
|
|
|
27,757 |
|
|
|
14,116 |
|
Net Loss Attributable to |
$ |
(74,789 |
) |
|
$ |
(28,157 |
) |
|
$ |
(268,323 |
) |
|
$ |
(80,695 |
) |
Per share data: |
|
|
|
|
|
|
|
||||||||
Net loss attributable to |
$ |
(74,789 |
) |
|
$ |
(28,157 |
) |
|
$ |
(268,323 |
) |
|
$ |
(80,695 |
) |
Less: Undistributed earnings allocated to participated securities |
|
— |
|
|
|
(3,153 |
) |
|
|
(12,205 |
) |
|
|
(13,494 |
) |
Less: Deemed dividend distribution |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(23,612 |
) |
Net loss attributed to |
$ |
(74,789 |
) |
|
$ |
(31,310 |
) |
|
$ |
(280,528 |
) |
|
$ |
(117,801 |
) |
Net loss per share attributable to |
|
|
|
|
|
|
|
||||||||
Basic and Diluted(3) |
$ |
(0.11 |
) |
|
$ |
(0.16 |
) |
|
$ |
(0.73 |
) |
|
$ |
(0.61 |
) |
Non-GAAP adjusted net income (loss)(4) |
$ |
(14,440 |
) |
|
$ |
11,283 |
|
|
$ |
(28,981 |
) |
|
$ |
36,879 |
|
Non-GAAP adjusted net income per share: |
|
|
|
|
|
|
|
||||||||
Basic(3) |
$ |
(0.02 |
) |
|
$ |
0.06 |
|
|
$ |
(0.08 |
) |
|
$ |
0.19 |
|
Diluted(3) |
$ |
(0.02 |
) |
|
$ |
0.03 |
|
|
$ |
(0.08 |
) |
|
$ |
0.11 |
|
Weighted average shares outstanding: |
|
|
|
|
|
|
|
||||||||
Basic(3) |
|
679,431,901 |
|
|
|
196,023,981 |
|
|
|
381,831,895 |
|
|
|
194,490,947 |
|
Diluted(3) |
|
964,179,889 |
|
|
|
439,122,774 |
|
|
|
666,968,467 |
|
|
|
345,551,431 |
|
(1) The following table sets forth share-based compensation for the periods indicated below:
|
Three Months Ended |
|
Nine Months Ended |
||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||
Research and development |
$ |
16,208 |
|
$ |
1,168 |
|
$ |
76,451 |
|
$ |
26,242 |
Sales and marketing |
|
15,645 |
|
|
631 |
|
|
54,534 |
|
|
17,410 |
General and administrative |
|
28,449 |
|
|
2,058 |
|
|
92,022 |
|
|
19,322 |
Total share-based compensation in operating expenses |
$ |
60,302 |
|
$ |
3,857 |
|
$ |
223,007 |
|
$ |
62,974 |
(2) Amounts for the nine months ended
(3) Prior period amounts have been retroactively adjusted to reflect the 1:186.9 stock split effected on
(4) See “Reconciliation of Non-GAAP Financial Measures” for a reconciliation of this and adjusted EBITDA, another non-GAAP measure.
|
|||||||
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION |
|||||||
AS OF |
|||||||
(In thousands) |
|||||||
|
|
|
|
||||
|
2022 |
|
2021 |
||||
Assets |
(Unaudited) |
|
(Audited) |
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
327,896 |
|
|
$ |
190,778 |
|
Restricted cash |
|
34,161 |
|
|
|
7,000 |
|
Short-term deposits |
|
— |
|
|
|
5,020 |
|
Fees and other receivables |
|
52,122 |
|
|
|
32,332 |
|
Investments in loans and securities |
|
2,446 |
|
|
|
5,142 |
|
Prepaid expenses and other current assets |
|
22,512 |
|
|
|
6,263 |
|
Total current assets |
|
439,137 |
|
|
|
246,535 |
|
Restricted cash |
|
4,762 |
|
|
|
6,797 |
|
Fees and other receivables |
|
31,250 |
|
|
|
19,208 |
|
Investments in loans and securities |
|
442,840 |
|
|
|
277,582 |
|
Equity method and other investments |
|
25,807 |
|
|
|
14,841 |
|
Right-of-use asset |
|
66,366 |
|
|
|
— |
|
Property and equipment, net |
|
28,202 |
|
|
|
7,648 |
|
Deferred tax assets, net |
|
8,501 |
|
|
|
5,681 |
|
Deferred offering costs |
|
— |
|
|
|
11,966 |
|
Prepaid expenses and other assets |
|
2,706 |
|
|
|
— |
|
Total non-current assets |
|
610,434 |
|
|
|
343,723 |
|
Total Assets |
$ |
1,049,571 |
|
|
$ |
590,258 |
|
Liabilities and Shareholders’ Equity |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Accounts payable |
$ |
2,483 |
|
|
$ |
11,580 |
|
Accrued expenses and other liabilities |
|
40,343 |
|
|
|
17,093 |
|
Operating lease liability - current |
|
8,983 |
|
|
|
— |
|
Secured borrowing - current |
|
26,251 |
|
|
|
— |
|
Income taxes payable - current |
|
10,924 |
|
|
|
— |
|
Total current liabilities |
|
88,984 |
|
|
|
28,673 |
|
Non-current liabilities: |
|
|
|
||||
Warrant liability |
|
3,080 |
|
|
|
27,469 |
|
Secured borrowing - non-current |
|
87,503 |
|
|
|
37,905 |
|
Operating lease liability - non-current |
|
53,501 |
|
|
|
— |
|
Income taxes payable - non-current |
|
22,773 |
|
|
|
11,812 |
|
Total non-current liabilities |
|
166,857 |
|
|
|
77,186 |
|
Total liabilities |
|
255,841 |
|
|
|
105,859 |
|
Redeemable convertible preferred shares |
|
— |
|
|
|
307,047 |
|
Shareholders’ equity: |
|
|
|
||||
Additional paid-in capital |
|
947,381 |
|
|
|
113,170 |
|
Accumulated deficit |
|
(380,201 |
) |
|
|
(111,878 |
) |
|
|
567,180 |
|
|
|
1,292 |
|
Noncontrolling interests |
|
226,550 |
|
|
|
176,060 |
|
Total shareholders’ Equity |
|
793,730 |
|
|
|
177,352 |
|
Total Liabilities and Shareholders’ Equity |
$ |
1,049,571 |
|
|
$ |
590,258 |
|
|
|||||||
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||||
FOR NINE MONTHS ENDED |
|||||||
|
Nine Months Ended |
||||||
|
2022 |
|
2021 |
||||
Cash flows from operating activities |
|
|
|
||||
Net loss |
$ |
(240,566 |
) |
|
$ |
(66,579 |
) |
Adjustments to reconcile net income (loss) to net cash used in operating activities: |
|
|
|
||||
Equity method income (loss) |
|
(5,670 |
) |
|
|
2 |
|
Depreciation and amortization |
|
4,077 |
|
|
|
489 |
|
Share-based compensation |
|
223,007 |
|
|
|
62,974 |
|
Fair value adjustment to warrant liability |
|
(9,408 |
) |
|
|
51,477 |
|
Issuance of ordinary shares related to commitment shares |
|
1,000 |
|
|
|
— |
|
Loss from investment in loans and securities |
|
10,706 |
|
|
|
— |
|
Change in operating assets and liabilities: |
|
|
|
||||
Fees and other receivables |
|
(31,832 |
) |
|
|
(16,929 |
) |
Deferred tax assets, net |
|
(2,820 |
) |
|
|
(2,979 |
) |
Prepaid expenses and other assets |
|
(18,530 |
) |
|
|
(17,221 |
) |
Right-of-use asset |
|
2,322 |
|
|
|
— |
|
Accounts payable |
|
(9,097 |
) |
|
|
4,242 |
|
Accrued expenses and other liabilities |
|
23,250 |
|
|
|
8,265 |
|
Operating lease liability |
|
(6,204 |
) |
|
|
— |
|
Income tax payable |
|
21,885 |
|
|
|
14,059 |
|
Net cash (used in) provided by operating activities |
|
(37,880 |
) |
|
|
37,800 |
|
Cash flows from investing activities |
|
|
|
||||
Proceeds from the sale/maturity/prepayment of: |
|
|
|
||||
Investments in loans and securities |
|
88,538 |
|
|
|
27,935 |
|
Short-term deposits |
|
5,020 |
|
|
|
— |
|
Equity method and other investments |
|
453 |
|
|
|
925 |
|
Payments for the purchase of: |
|
|
|
||||
Investments in loans and securities |
|
(261,806 |
) |
|
|
(142,146 |
) |
Property and equipment |
|
(18,266 |
) |
|
|
(1,517 |
) |
Equity method and other investments |
|
(5,749 |
) |
|
|
(22,991 |
) |
Short-term deposits |
|
— |
|
|
|
(51,446 |
) |
Net cash used in investing activities |
|
(191,810 |
) |
|
|
(189,240 |
) |
Cash flows from financing activities |
|
|
|
||||
Proceeds from sale of ordinary shares in connection with the Business Combination and |
|
291,872 |
|
|
|
— |
|
Proceeds from issuance of redeemable convertible preferred shares, net |
|
— |
|
|
|
172,645 |
|
Proceeds from issuance of ordinary share warrants, net |
|
— |
|
|
|
20,807 |
|
Proceeds from secured borrowing |
|
94,094 |
|
|
|
— |
|
Proceeds received from noncontrolling interests |
|
92,988 |
|
|
|
129,970 |
|
Proceeds from revolving credit facility |
|
26,000 |
|
|
|
— |
|
Proceeds from exercise of stock options |
|
1,480 |
|
|
|
171 |
|
Distribution made to noncontrolling interests |
|
(70,255 |
) |
|
|
(54,457 |
) |
Distribution made to revolving credit facility |
|
(26,000 |
) |
|
|
— |
|
Distribution made to secured borrowing |
|
(18,245 |
) |
|
|
— |
|
Payment for deferred offering costs |
|
— |
|
|
|
(4,278 |
) |
Net cash provided by financing activities |
|
391,934 |
|
|
|
264,858 |
|
Net increase in cash, cash equivalents and restricted cash |
|
162,244 |
|
|
|
113,418 |
|
Cash, cash equivalents and restricted cash, beginning of period |
|
204,575 |
|
|
|
5,880 |
|
Cash, cash equivalents and restricted cash, end of period |
$ |
366,819 |
|
|
$ |
119,298 |
|
Reconciliation of cash, cash equivalents, and restricted cash within the condensed consolidated statements of financial position to the amounts shown in the statements of cash flow above: |
|
|
|
||||
Cash and cash equivalents |
$ |
327,896 |
|
|
$ |
101,236 |
|
Restricted cash - current |
|
34,161 |
|
|
|
12,000 |
|
Restricted cash - non-current |
|
4,762 |
|
|
|
6,062 |
|
Total cash, cash equivalents, and restricted cash |
$ |
366,819 |
|
|
$ |
119,298 |
|
|
|||||||||||||||
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES (UNAUDITED) |
|||||||||||||||
FOR THREE AND NINE MONTHS ENDED |
|||||||||||||||
(In thousands) |
|||||||||||||||
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
Net Loss Attributable to |
$ |
(74,789 |
) |
|
$ |
(28,157 |
) |
|
$ |
(268,323 |
) |
|
$ |
(80,695 |
) |
Adjusted to exclude the following: |
|
|
|
|
|
|
|
||||||||
Share-based compensation |
|
60,302 |
|
|
|
3,857 |
|
|
|
223,007 |
|
|
|
62,974 |
|
Fair value adjustment to warrant liability |
|
(3,000 |
) |
|
|
32,460 |
|
|
|
(9,408 |
) |
|
|
51,477 |
|
Non-recurring expenses |
|
3,047 |
|
|
|
3,123 |
|
|
|
25,743 |
|
|
|
3,123 |
|
Adjusted Net Income (Loss) |
|
(14,440 |
) |
|
|
11,283 |
|
|
|
(28,981 |
) |
|
|
36,879 |
|
Adjusted to exclude the following: |
|
|
|
|
|
|
|
||||||||
Interest expenses |
|
243 |
|
|
|
— |
|
|
|
3,420 |
|
|
|
— |
|
Income tax expense |
|
6,065 |
|
|
|
3,624 |
|
|
|
25,604 |
|
|
|
11,417 |
|
Depreciation and amortization |
|
2,929 |
|
|
|
207 |
|
|
|
4,077 |
|
|
|
489 |
|
Adjusted EBITDA |
$ |
(5,203 |
) |
|
$ |
15,114 |
|
|
$ |
4,120 |
|
|
$ |
48,785 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20221110006013/en/
Investors & Analysts
Head of Investor Relations
IR@pagaya.com
Media & Press
VP, Head of
Press@pagaya.com
Source: